Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Oramed Pharma (ORMP)

Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oramed Pharma 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 USA

www.oramed.com Employees: 13 P: 844-967-2633

Sector:

Medical

Description:

Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel.

Key Statistics

Overview:

Market Capitalization, $K 146,471
Enterprise Value, $K 92,051
Shares Outstanding, K 39,802
Float, K 32,717
% Float 82.20%
Short Interest, K 315
Short Float 0.79%
Days to Cover 1.64
Short Volume Ratio 0.41
% of Insider Shareholders 17.80%
% of Institutional Shareholders 12.73%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -19,060 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ 13,290 K
EBIT, $ -13,680 K
EBITDA, $ -13,490 K

Growth:

1-Year Return 58.62%
3-Year Return 78.64%
5-Year Return -33.45%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth -158.54%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 11/13/25
Next Earnings Date 03/26/26
Earnings Per Share ttm -0.71
EPS Growth vs. Prev Qtr 100.00%
EPS Growth vs. Prev Year 100.00%
Annual Dividend & Yield (Paid) 0.25 (6.79%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Most Recent Dividend 0.250 on 01/16/26
Next Ex-Dividends Date 01/16/26
Dividend Payable Date 01/26/26
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 01/23/13

ORMP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -5.57%
Return-on-Assets % -5.22%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales 78.00
Price/Cash Flow N/A
Price/Book 0.75
Book Value/Share 3.76
Interest Coverage -17.73
60-Month Beta 1.19

ORMP Dividends

Date Value
01/16/26 $0.2500
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar